Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lee J. Smolen, James C. Gahn, Ghaith Mitri & Aki Shiozawa. (2016) Febuxostat in the management of gout: a cost-effectiveness analysis. Journal of Medical Economics 19:3, pages 265-276.
Read now
Read now
Periklis Dousdampanis, Konstantina Trigka, Carlos G. Musso & Costas Fourtounas. (2014) Hyperuricemia and chronic kidney disease: an enigma yet to be solved. Renal Failure 36:9, pages 1351-1359.
Read now
Read now
Andrew Whelton, Patricia A. MacDonald, Solomon Chefo & Lhanoo Gunawardhana. (2013) Preservation of Renal Function during Gout Treatment with Febuxostat: A Quantitative Study. Postgraduate Medicine 125:1, pages 106-114.
Read now
Read now
MD Kontogianni, C Chrysohoou, DB Panagiotakos, E Tsetsekou, A Zeimbekis, C Pitsavos & C Stefanadis. (2012) Adherence to the Mediterranean diet and serum uric acid: the ATTICA study. Scandinavian Journal of Rheumatology 41:6, pages 442-449.
Read now
Read now
Articles from other publishers (29)
Abubakar Yerima, Mohammad Maina Sulaiman & Adamu Abba Adamu. (2023) Pattern of gout and its association with chronic kidney disease in Maiduguri, northeastern Nigeria. Clinical Rheumatology 42:7, pages 1775-1782.
Crossref
Crossref
Danilo Lemes Naves Gonçalves, Tiago Ricardo Moreira & Luciana Saraiva da Silva. (2022) A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease. Scientific Reports 12:1.
Crossref
Crossref
Jie Wei, Hyon K. ChoiTuhina Neogi, Nicola DalbethRobert Terkeltaub, Lisa K. Stamp, Houchen Lyu, Natalie McCormick, Jingbo NiuChao ZengGuanghua Lei & Yuqing Zhang. (2022) Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease. Annals of Internal Medicine 175:4, pages 461-470.
Crossref
Crossref
Bon San Koo, Hye-Jin Jeong, Chang-Nam Son, Sang-Hyon Kim, Gheun-Ho Kim & Jae-Bum Jun. (2021) J-shaped Relationship Between Chronic Kidney Disease and Serum Uric Acid Levels: A Cross-sectional Study on the Korean Population. Journal of Rheumatic Diseases 28:4, pages 225-233.
Crossref
Crossref
Tao Yuan, Shixuan Liu, Yingyue Dong, Yong Fu, Yan Tang & Weigang Zhao. (2020) Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial. Diabetology & Metabolic Syndrome 12:1.
Crossref
Crossref
Cheng-Sheng Yu, Chang-Hsien Lin, Yu-Jiun Lin, Shiyng-Yu Lin, Sen-Te Wang, Jenny L Wu, Ming-Hui Tsai & Shy-Shin Chang. (2020) Clustering Heatmap for Visualizing and Exploring Complex and High-dimensional Data Related to Chronic Kidney Disease. Journal of Clinical Medicine 9:2, pages 403.
Crossref
Crossref
Ting-Ting Chung, Kuang-Hui Yu, Chang-Fu Kuo, Shue-Fen Luo, Meng-Jiun Chiou, Wen-Ching Lan, Jung-Sheng Chen, Wen-Yi Tseng, Ao-Ho Hsieh & Lian-Chin Wang. (2019) Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Woo-Joong Kim, Jung Soo Song & Sang Tae Choi. (2019) The Role of a “Treat-to-Target” Approach in the Long-Term Renal Outcomes of Patients with Gout. Journal of Clinical Medicine 8:7, pages 1067.
Crossref
Crossref
Tsu-Chen Lin, Lie Yee Hung, Ying-Chun Chen, Wei-Cheng Lo, Chun Hung Lin, Ka-Wai Tam & Mei-Yi Wu. (2019) Effects of febuxostat on renal function in patients with chronic kidney disease. Medicine 98:29, pages e16311.
Crossref
Crossref
Marie Doualla, Marie Patrice Halle, Jude Moutchia, Steve Tegang & Gloria Ashuntantang. (2018) Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon. BMC Nephrology 19:1.
Crossref
Crossref
Bartosz Słomiński, Maria Skrzypkowska, Monika Ryba-Stanisławowska & Agnieszka Brandt. (2018) Sex-related association of serum uric acid with inflammation, kidney function and blood pressure in type 1 diabetic patients. Pediatric Diabetes 19:5, pages 1014-1019.
Crossref
Crossref
Muhammed Karadeniz, Hüseyin Kandemir, Taner Sarak & Çağlar Alp. (2018) Akut koroner sendromda perkütan koroner girişim yapılan hastalarda kontrast nefropati prevalansıThe prevalence of contrast nephropathy in patients undergoing percutaneous coronary intervention in acute coronary syndrome. Journal of Health Sciences and Medicine 1:2, pages 34-39.
Crossref
Crossref
M Savira, Rusdiana & M Syahputra. (2018) Association of serum uric acid level and blood pressure in type 2 diabetes mellitus. IOP Conference Series: Earth and Environmental Science 125, pages 012169.
Crossref
Crossref
Yao-Peng Hsieh, Chia-Chu Chang, Yu Yang, Yao-Ko Wen, Ping-Fang Chiu & Chi-Chen Lin. (2017) The role of uric acid in chronic kidney disease patients. Nephrology 22:6, pages 441-448.
Crossref
Crossref
Jai P Yogi & Anita Semar. (2017) Association of Hyperuricemia and Urinary Albumin Excretion with Glycosylated Hemoglobin in Patients with Type II Diabetes Mellitus. Journal of Mahatma Gandhi University of Medical Sciences and Technology 2:1, pages 1-6.
Crossref
Crossref
Ching-Wei Tsai, Shih-Yi Lin, Chin-Chi Kuo & Chiu-Ching Huang. (2017) Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review. PLOS ONE 12:1, pages e0170393.
Crossref
Crossref
Cuiling Zhu, Ran Cui, Mingming Gao, Sharvan Rampersad, Hui You, Chunjun Sheng, Peng Yang, Hui Sheng, Xiaoyun Cheng, Le Bu & Shen Qu. (2017)
The Associations of Serum Uric Acid with Obesity-Related
Acanthosis nigricans
and Related Metabolic Indices
. International Journal of Endocrinology 2017, pages 1-9.
Crossref
Crossref
Lee J. Smolen, James C. Gahn, Ghaith Mitri & Aki Shiozawa. (2016) The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective. Clinical Therapeutics 38:7, pages 1710-1725.
Crossref
Crossref
Chang-Fu Kuo, Matthew J Grainge, Christian Mallen, Weiya Zhang & Michael Doherty. (2016) Comorbidities in patients with gout prior to and following diagnosis: case-control study. Annals of the Rheumatic Diseases 75:1, pages 210-217.
Crossref
Crossref
Tahir Kanji, Mandark Gandhi, Catherine M Clase & Robert Yang. (2015) Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology 16:1.
Crossref
Crossref
Hakan Nacak, Merel van Diepen, Abdul R. Qureshi, Juan J. Carrero, Theo Stijnen, Friedo W. Dekker & Marie Evans. (2015) Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease. Nephrology Dialysis Transplantation 30:12, pages 2039-2045.
Crossref
Crossref
Hakan Nacak, Merel van Diepen, Moniek CM de Goeij, Joris I Rotmans & Friedo W Dekker. (2014) Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients. BMC Nephrology 15:1.
Crossref
Crossref
Yuzhang Zhu, Yaqiu Hu, Tianliang Huang, Yongneng Zhang, Zhi Li, Chaohuan Luo, Yinfeng Luo, Huier Yuan, Ichiro Hisatome, Tetsuya Yamamoto & Jidong Cheng. (2014) High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochemical and Biophysical Research Communications 447:4, pages 707-714.
Crossref
Crossref
Yongneng Zhang, Tetsuya Yamamoto, Ichiro Hisatome, Youfeng Li, Weijie Cheng, Ning Sun, Bozhi Cai, Tianliang Huang, Yuzhang Zhu, Zhi Li, Xubin Jing, Rui Zhou & Jidong Cheng. (2013) Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells. Molecular and Cellular Endocrinology 375:1-2, pages 89-96.
Crossref
Crossref
David M. Maahs, Luiza Caramori, David Z. I. Cherney, Andrzej T. Galecki, Chuanyun Gao, Diana Jalal, Bruce A. Perkins, Rodica Pop-Busui, Peter Rossing, Michael Mauer & Alessandro Doria. (2013) Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study. Current Diabetes Reports 13:4, pages 550-559.
Crossref
Crossref
Macaulay Onuigbo. (2013) Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents. Nephron Extra 3:1, pages 36-49.
Crossref
Crossref
Diana I. Jalal, Michel Chonchol, Wei Chen & Giovanni Targher. (2013) Uric Acid as a Target of Therapy in CKD. American Journal of Kidney Diseases 61:1, pages 134-146.
Crossref
Crossref
G. Zoppini, G. Targher & E. Bonora. (2014) The role of serum uric acid in cardiovascular disease in Type 2 diabetic and non-diabetic subjects: A narrative review. Journal of Endocrinological Investigation 34:11, pages 881-886.
Crossref
Crossref
Mehmet Kanbay, Bulent Huddam, Alper Azak, Yalcin Solak, Gulay Kocak Kadioglu, Ismail Kirbas, Murat Duranay, Adrian Covic & Richard J. Johnson. (2011) A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function. Clinical Journal of the American Society of Nephrology 6:8, pages 1887-1894.
Crossref
Crossref